Benedicto Crespo Facorro is a psychiatrist who works as a clinician,
researcher, and educator in psychiatry and mental health; notably known for his
research work in the area of early psychosis and schizophrenia. Dr. Crespo-Facorro has led the first
psychosis early intervention programs in Spain (PAFIP) for over two decades,
generating a clinical cohort of high relevance in the field of schizophrenia
with the recognition of institutions and patient associations.
Crespo-Facorro is currently Director of the Mental Health Unit at Virgen
del Rocio University Hospital (Seville) (2019-), Full Professor of Psychiatry
in the school of medicine at University of Seville (2019-), Elected Fellow of
the Royal National Academy of Medicine of Spain, holding the Psychiatry Seat
(2025-), and the Principal Investigator of the Translational Psychiatry Group in
CIBERSAM CB/07/09/2001 (2008-) and in Seville Biomedical Research Institute
CTS-1086 (2019-).
He is also currently adjunct professor of psychiatry at Baylor (Houston,
USA) and Milan (Italy) Universities collaborating in the teaching of imaging
genomic and the state of the art of biomarkers in schizophrenia (graduate and
postgraduate). And in 2021 he was named
Honoris Causa Professor at the Universidad Favaloro Argentina.
Prof. Crespo-Facorro contributed to establish the National Network on
Mental Health Research (CIBERSAM) where he coordinated the nation-wide
Schizophrenia Research Program from 2015 to 2021. Dr. Crespo-Facorro is one of
the only four researchers from Spain listed in the authors’ collaborative
network of the authors that published the greatest number of research papers on
antipsychotics and schizophrenia over the last 50 years (PMID: 35303594).
He supervised 16 PhD theses to date. He is the author of two patents and
was the director of the Neuroimaging unit at IDIVAL (2009-2019). He is
the current Editor-in-Chief of the Journal of Psychiatry and Mental Health
(JCR, Q1) (2019-). And reviewer of more than 10 peer-reviewed
journals, among them Molecular Psychiatry, JAMA Psychiatry, American Journal of
Psychiatry, Biological Psychiatry, and The New England Journal of Medicine.
Also, Committee Board Member of the Journal of Affective Disorders, and
Psychiatry Investigation.
According to SCOPUS as of 14 March 2025, his bibliometric analysis reflects 480 indexed publications, with 26660 citations received and an H Index = 70.
